Bearish Monday For Marijuana Stocks - Maple Leaf Green World, 22nd Century Group Among Top Gainers - Cannabix Technologies (OTC:BLOZF), Blueberries Medical (OTC:BBRRF)

Curaleaf Holdings confirmed its previously announced 1-for-3 reverse stock split of subordinate voting shares will take effect June 5, 2026. Shares will keep trading on the TSX under “CURA” with a new CUSIP (23126M300). The company has 698,731,895 shares outstanding, expected to fall to about 232,910,632; no fractional shares will be issued. A concurrent 1-for-3 consolidation of multiple voting shares will also occur.

The article highlights three higher-risk growth stocks for long-term investors: Joby Aviation (JOBY), Curaleaf Holdings (CURLF), and Pony AI (PONY). It says Joby has a ~$12B market cap but lacks U.S. aircraft approval and posted a $930M loss last year. Curaleaf reported 2025 operating income of $25M on ~$1.3B revenue. Pony AI, with ~$5B market cap, reported Q1 revenue of $34.3M (+145% YoY) but an operating loss of $58.3M over the past three months.

The article compares U.S. multi-state cannabis operators Green Thumb Industries (GTBIF) and Curaleaf Holdings (CURLF). It says Curaleaf is the largest MSO by TTM sales (~$1.3B) versus Green Thumb (~$1.2B). Both face regulatory and tax uncertainty under IRS Section 280E. Green Thumb has positive GAAP EPS for five years and trades at ~3.5x EV/EBITDA versus Curaleaf ~15.5x, while Curaleaf targets Europe and plans an OTC-to-exchange uplisting pending approval.

22nd Century Group (Nasdaq: XXII) announced the launch of Pinnacle Pure, a new tobacco and water style combustible cigarette, expanding its high-margin Pinnacle platform. This new product is expected to be sold through major U.S. national retailers and over 2,000 locations, building on the company's existing Pinnacle VLN® expansion. The launch aims to broaden the Pinnacle brand's reach, deepen retail penetration, and strengthen the company's revenue and margin growth.

22nd Century Group, Inc. (XXII) filed a prospectus supplement on May 1, 2026, to allow for the sale of up to $6.4 million in common stock through an existing agreement with Needham & Company, LLC. The company has not sold any shares under this program in the past year, indicating a potential future capital raise that could dilute current shareholders. TipRanks’ AI Analyst, Spark, rates XXII as Underperform due to weak financial performance and negative technical indicators.

22nd Century Group, Inc. (XXII) has filed a shelf registration statement to offer up to $250 million in various securities, including debt, common stock, preferred stock, warrants, subscription rights, securities purchase contracts, and units. The filing also includes an amendment to its at-the-market (ATM) sales agreement with Needham & Company, LLC, allowing for the sale of up to $1.84 million in common stock. As of March 26, 2026, the company reported 721,338 shares of common stock outstanding at a price of $2.94 per share.